MiCAN Technologies Inc. announced that it has entered into a contract for a private placement of 400 common shares at an issue price of ¥54,000 for gross proceeds of ¥21,600,000 on October 30, 2019. The transaction will include participation from Nissui Pharmaceutical Co., Ltd. (TSE:4550). Prior to the transaction, the capital of the company is ¥80,090,000. The shares are issued as part of third party allotment method. The transaction is expected to closed on October 31, 2019.